Vasiliauskas E - Search Results

1

Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).

Gu P, Dube S, Lee Y, Yang S, Li D, Haritunians T, Vasiliauskas E, Bonthala N, Syal G, Yarur A, Ziring D, Targan S, Rabizadeh S, Melmed GY, Fleshner P, McGovern DPB. Gu P, et al. Among authors: vasiliauskas e. Dig Dis Sci. 2024 Jan;69(1):235-245. doi: 10.1007/s10620-023-08192-w. Epub 2023 Nov 28. Dig Dis Sci. 2024. PMID: 38015321 Free PMC article.

2

Is acute fatty liver of pregnancy a metabolic defect?

Vasiliauskas E, Rosenthal P. Vasiliauskas E, et al. Am J Gastroenterol. 1994 Oct;89(10):1908-10. Am J Gastroenterol. 1994. PMID: 7942700 No abstract available.

3

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.

Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Vasiliauskas EA, et al. Gastroenterology. 1996 Jun;110(6):1810-9. doi: 10.1053/gast.1996.v110.pm8964407. Gastroenterology. 1996. PMID: 8964407

4

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications.

Facklis K, Plevy SE, Vasiliauskas EA, Kam L, Taylor K, Targan SR, Fleshner PR. Facklis K, et al. Among authors: vasiliauskas ea. Dis Colon Rectum. 1999 May;42(5):601-5; discussion 605-6. doi: 10.1007/BF02234133. Dis Colon Rectum. 1999. PMID: 10344681

5

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

Vasiliauskas EA, Kam LY, Abreu-Martin MT, Hassard PV, Papadakis KA, Yang H, Zeldis JB, Targan SR. Vasiliauskas EA, et al. Gastroenterology. 1999 Dec;117(6):1278-87. doi: 10.1016/s0016-5085(99)70277-5. Gastroenterology. 1999. PMID: 10579968 Clinical Trial.

6

Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.

Hassard PV, Vasiliauskas EA, Kam LY, Targan SR, Abreu MT. Hassard PV, et al. Among authors: vasiliauskas ea. Inflamm Bowel Dis. 2000 Feb;6(1):16-20. doi: 10.1097/00054725-200002000-00003. Inflamm Bowel Dis. 2000. PMID: 10701145

7

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.

Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Rowe FA, et al. Among authors: vasiliauskas ea. Am J Gastroenterol. 2000 Aug;95(8):2000-8. doi: 10.1111/j.1572-0241.2000.02186.x. Am J Gastroenterol. 2000. PMID: 10950049

8

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Vasiliauskas EA, et al. Gut. 2000 Oct;47(4):487-96. doi: 10.1136/gut.47.4.487. Gut. 2000. PMID: 10986208 Free PMC article.

9

Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Papadakis KA, et al. Among authors: vasiliauskas ea. Am J Gastroenterol. 2001 Jul;96(7):2137-42. doi: 10.1111/j.1572-0241.2001.03949.x. Am J Gastroenterol. 2001. PMID: 11467645

10

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.

Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Among authors: vasiliauskas ea. Inflamm Bowel Dis. 2001 Aug;7(3):181-9. doi: 10.1097/00054725-200108000-00001. Inflamm Bowel Dis. 2001. PMID: 11515842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters